CSTL Castle Biosciences
Castle Biosciences earnings company data as of 4:45 AM ET 11/6
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | -0.35 | -0.13 | Beat |
| Rev | $92.5M | $102.9M | Beat +11.2% |
Insider trades
Open-market buys and sales by CSTL's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $3M sold by 4 insiders outside a trading plan
- $16.7M sold by 4 insiders under 10b5-1 plans
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$523K 14,496 shares at $36.10Traded Nov 2 Filed Nov 4
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$240K 6,578 shares at $36.42 15% of stakeTraded Oct 28 Filed Oct 30
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$109K 3,288 shares at $33.08 6.7% of stakeTraded Oct 26 Filed Oct 28
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$463K 14,496 shares at $31.91Traded Oct 19 Filed Oct 21
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$111K 3,288 shares at $33.64 6.3% of stakeTraded Oct 12 Filed Oct 14
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$516K 14,496 shares at $35.57Traded Oct 5 Filed Oct 7
-
Kristen M Oelschlager COOPlanned sale$149K 4,153 shares at $35.95 24% of stakeTraded Oct 1 Filed Oct 5
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$232K 6,577 shares at $35.29 11% of stakeTraded Sep 29–30 Filed Oct 1
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$512K 14,496 shares at $35.33Traded Sep 21 Filed Sep 23
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$223K 6,600 shares at $33.73 10% of stakeTraded Sep 14–15 Filed Sep 16
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$465K 14,518 shares at $32.02Traded Sep 11 Filed Sep 15
-
Kristen M Oelschlager COOPlanned sale$139K 4,152 shares at $33.39 24% of stakeTraded Sep 1 Filed Sep 3
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$57K 1,730 shares at $32.81 2.6% of stakeTraded Aug 31 Filed Sep 2
-
Derek J Maetzold Pres. & Chief Exec. OfficerPlanned sale$616K 18,560 shares at $33.20Traded Aug 28 Filed Sep 1
-
Tobin W Juvenal Chief Commercial OfficerPlanned sale$317K 9,050 shares at $35.04 12% of stakeTraded Aug 25 Filed Aug 27
Also filed in the last 12 months, not counted as buying or selling: 50 option exercises, 16 share withholdings for taxes, and 4 stock grants.
SEC filings
Recent issuer filings from EDGAR, 5 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon